Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterations

Authors: Lalande, Catherine; Drouin-Chartier, Jean-PhilippeTremblay, AndréCouture, PatrickVeilleux, Alain
Abstract: Background: Evidence suggests that pathophysiological conditions such as obesity and type 2 diabetes (T2D) are associated with morphologic and metabolic alterations in the small intestinal mucosa. Exploring these alterations generally requires invasive methods, limiting data acquisition to subjects with enteropathies or undergoing bariatric surgery. We aimed to evaluate small intestine epithelial cell homeostasis in a cohort of men covering a wide range of adiposity and glucose homoeostasis statuses. Methods: Plasma levels of citrulline, a biomarker of enterocyte mass, and I-FABP, a biomarker of enterocyte death, were measured by UHPLC‑MS and ELISA in 154 nondiabetic men and 67 men with a T2D diagnosis. Results: Plasma citrulline was signifcantly reduced in men with insulin resistance and T2D compared to insulin sensi‑ tive men. Decreased citrulline levels were, however, not observed in men with uncontrolled metabolic parameters during T2D. Plasma I-FABP was signifcantly higher in men with T2D, especially in presence of uncontrolled glycemic and lipid profle parameters. Integration of both parameters, which estimate enterocyte turnover, was associated with glucose homeostasis as well as with T2D diagnosis. Diferences in biomarkers levels were independent of age and BMI and glucose fltration rates. Conclusions: Our study supports a decreased functional enterocyte mass and an increased enterocyte death rate in presence of metabolic alterations but emphasizes that epithelial cell homeostasis is especially altered in presence of severe insulin resistance and T2D. The marked changes in small intestine cellularity observed in obesity and diabe‑ tes are thus suggested to be part of gut dysfunctions, mainly at an advanced stage of the disease.
Document Type: Article de recherche
Issue Date: 9 April 2020
Open Access Date: 7 August 2020
Document version: VoR
Creative Commons Licence: https://creativecommons.org/licenses/by/4.0
Permalink: http://hdl.handle.net/20.500.11794/39989
This document was published in: Diabetology and Metabolic Syndrome, Vol. 12 (31) (2020)
https://doi.org/10.1186/s13098-020-00530-6
BioMed Central
Alternative version: 10.1186/s13098-020-00530-6
PMC7144049
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
s13098-020-00530-6.pdf1.31 MBAdobe PDFThumbnail
View/Open
All documents in CorpusUL are protected by Copyright Act of Canada.